<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-3SR47BPX</identifier><date>2012</date><creator>Škerget, Matevž</creator><relation>documents/doc/3/URN_NBN_SI_doc-3SR47BPX_001.htm</relation><relation>documents/doc/3/URN_NBN_SI_doc-3SR47BPX_001.pdf</relation><relation>documents/doc/3/URN_NBN_SI_doc-3SR47BPX_001.txt</relation><format format_type="volume">81</format><format format_type="type">article</format><format format_type="extent">str. II-92-II-98</format><format format_type="issue">suppl.</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">266989568</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-3SR47BPX</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">kronična limfocitna levkemija</subject><subject language_type_id="slv">levkemija</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>First-line treatment of chronic lymphocytic leukemia with three combined chemotherapy regimens</title><title>Pomen prvega zdravljenja kronične limfocitne levkemije s tremi uveljavljenimi shemami</title></Record>